Buprenorphine as a Treatment in Opiate Dependent Pain Patients

• Status: Terminated
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to determine if different doses of buprenorphine (either tapering doses or steady doses) are effective in managing chronic, non-cancer pain in individuals who also are addicted to opiate pain medicines.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: State University of New York at Buffalo
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone

Criteria

Inclusion Criteria:

• Clinical diagnosis of chronic refractory pain

• Clinical diagnosis of opiate dependency

Exclusion Criteria:

• unable to pay for medication

• enrolled in a methadone maintenance program

• homelessness

• major mental illness

• pregnant women

• prisoners

• terminal cancer pain